NCT00216853

Brief Summary

The purpose of this study is to determine the extent to which vaginal microflora and immune profiles of patients with urinary tract infection (UTI) differ from healthy controls.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2003

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2003

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

September 19, 2005

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 22, 2005

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2006

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2007

Completed
Last Updated

April 16, 2009

Status Verified

April 1, 2009

Enrollment Period

2.8 years

First QC Date

September 19, 2005

Last Update Submit

April 15, 2009

Conditions

Urinary Tract Infections

Study Arms (2)

Patients with Recurrent UTI

Healthy controls

Eligibility Criteria

Age20 Years - 80 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample

You may qualify if:

  • At least 2 recurrent UTIs within the last year
  • Written informed consent
  • No UTI within the past 5 years
  • Written informed consent

You may not qualify if:

  • Active UTI
  • Urinary tract anomalies
  • Evidence of a neurogenic bladder
  • Known immunodeficiencies
  • Use of antibiotics, within the last month
  • Concomitant use of oral steroids
  • Known renal calculi
  • Previous or ongoing chemotherapy
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Joseph's Health Centre

London, Ontario, Canada

Location

MeSH Terms

Conditions

Urinary Tract Infections

Condition Hierarchy (Ancestors)

InfectionsUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • Stephen Pautler, MD, FRCSC

    London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 19, 2005

First Posted

September 22, 2005

Study Start

September 1, 2003

Primary Completion

June 1, 2006

Study Completion

March 1, 2007

Last Updated

April 16, 2009

Record last verified: 2009-04

Locations

CA(1)